title: Treatment of ovarian cancer in young women.
abstract: Ovarian cancer accounts for approximately 22,000 cases annually in the United States. Although the vast majority of ovarian cancers occur in postmenopausal women and are of advanced stage, a significant subset occurs in young women. Among those subtypes having a predisposition for young women are malignant ovarian germ cell tumors, sex cord-stromal ovarian tumors, and tumors of low malignant potential. However, invasive epithelial ovarian cancers may also occur in young women, particularly the subtypes of low-grade serous carcinoma and mucinous carcinoma. This article details the diagnosis and optimal treatment of ovarian cancers subtypes in young women.
authors.affiliation: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1439, USA. dgershen@mdanderson.org
authors.forename: David M
authors.initials: DM
authors.lastname: Gershenson
mesh_terms: D002288:Adenocarcinoma, Mucinous / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D018284:Cystadenocarcinoma, Serous / Q000601:surgery; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D059247:Fertility Preservation; D006801:Humans; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009373:Neoplasms, Germ Cell and Embryonal / Q000628:therapy; D059351:Organ Sparing Treatments; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D010052:Ovariectomy; D018312:Sex Cord-Gonadal Stromal Tumors / Q000628:therapy